Trials / Completed
CompletedNCT03924453
Usability Study of the Pearl Fertility Tracking Device
Use and Effectiveness of a Digitally Integrated Ovulation Prediction Kits for Fertility Tracking - Pearl Powered by Proov
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 35 (actual)
- Sponsor
- MFB Fertility · Industry
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- —
Summary
This mobile application measures the level of certain hormones in the urine of a woman and is used to help pinpoint when the woman is/was most likely to get pregnant during her menstrual cycle.
Detailed description
The purpose of the study is to evaluate the accuracy of ovulation monitoring using hormone test strips in a digital way via a mobile application. Ovulation prediction kits consist of test strips that measure three different hormones - LH (luteinizing hormone), FSH (follicle stimulating hormone), PdG (pregnanediol). Through daily testing with the mobile application, it is possible to measure these hormones and build hormonal profiles along the menstrual cycle. This way we can accurately predict and confirm ovulation, as well as calculate the most fertile days in the cycle. There are multiple solutions that claim to accurately monitor fertility. However, some of these solutions use period statistics with high level of error, for example period trackers, or body temperature monitors. Some others use hormonal test strips in which reading/interpretation is not always easy. This study evaluates the accuracy of using hormone test strips in combination with an app that will digitally read and record data over time.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Pearl Powered by Proov | Participants self test in their homes and report back data via uploading onto an app and taking surveys. |
Timeline
- Start date
- 2017-12-01
- Primary completion
- 2019-12-31
- Completion
- 2019-12-31
- First posted
- 2019-04-23
- Last updated
- 2020-09-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03924453. Inclusion in this directory is not an endorsement.